Nonviral technologies can pave the way for CAR-NK cell therapy
Tobias Bexte(Goethe University Frankfurt), Evelyn Ullrich(Goethe University Frankfurt), Lisa Marie Reindl(Goethe University Frankfurt)
Cited by 19
Related Papers
High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia
|Frontiers in Immunology|2020|111
CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma
|OncoImmunology|2022|77
CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells
|Nature Communications|2024|71